scholarly journals The Science of Obesity Management: An Endocrine Society Scientific Statement

2018 ◽  
Vol 39 (2) ◽  
pp. 79-132 ◽  
Author(s):  
George A Bray ◽  
William E Heisel ◽  
Ashkan Afshin ◽  
Michael D Jensen ◽  
William H Dietz ◽  
...  
2012 ◽  
Vol 97 (9) ◽  
pp. E1579-E1639 ◽  
Author(s):  
Sherita Hill Golden ◽  
Arleen Brown ◽  
Jane A. Cauley ◽  
Marshall H. Chin ◽  
Tiffany L. Gary-Webb ◽  
...  

2017 ◽  
Vol 102 (12) ◽  
pp. 4343-4410 ◽  
Author(s):  
Eugene J Barrett ◽  
Zhenqi Liu ◽  
Mogher Khamaisi ◽  
George L King ◽  
Ronald Klein ◽  
...  

2017 ◽  
Vol 38 (2) ◽  
pp. 103-122 ◽  
Author(s):  
William F. Young ◽  
David A. Calhoun ◽  
Jacques W.M. Lenders ◽  
Michael Stowasser ◽  
Stephen C. Textor

2014 ◽  
Vol 58 (6) ◽  
pp. 587-599 ◽  
Author(s):  
Luiz Griz ◽  
Daniele Fontan ◽  
Patricia Mesquita ◽  
Marise Lazaretti-Castro ◽  
Victoria Zeghbi Cochenski Borba ◽  
...  

Objective: To conduct a literature review on the diagnosis and management of Paget’s disease of bone. Materials and methods: This scientific statement was generated by a request from the Brazilian Medical Association (AMB) to the Brazilian Society of Endocrinology and Metabolism (SBEM) as part of its Clinical Practice Guidelines program. Articles were identified by searching in PubMed and Cochrane databases as well as abstracts presented at the Endocrine Society, Brazilian Society for Endocrinology Annual Meetings and the American Society for Bone and Mineral Research Annual Meeting during the last 5 years. Grading quality of evidence and strength of recommendation were adapted from the first report of the Oxford Centre for Evidence-based Medicine. All grades of recommendation, including “D”, are based on scientific evidence. The differences between A, B, C and D, are due exclusively to the methods employed in generating evidence. Conclusion: We present a scientific statement on Paget’s disease of bone providing the level of evidence and the degree of recommendation regarding causes, clinical presentation as well as surgical and medical treatment. Arq Bras Endocrinol Metab. 2014;58(6):587-99


2012 ◽  
Vol 33 (3) ◽  
pp. 456-492 ◽  
Author(s):  
Clifford J. Rosen ◽  
John S. Adams ◽  
Daniel D. Bikle ◽  
Dennis M. Black ◽  
Marie B. Demay ◽  
...  

Diabetes Care ◽  
2015 ◽  
Vol 38 (10) ◽  
pp. 1964-1974 ◽  
Author(s):  
Richard A. Insel ◽  
Jessica L. Dunne ◽  
Mark A. Atkinson ◽  
Jane L. Chiang ◽  
Dana Dabelea ◽  
...  

2017 ◽  
Vol 38 (4) ◽  
pp. 267-296 ◽  
Author(s):  
Michael W Schwartz ◽  
Randy J Seeley ◽  
Lori M Zeltser ◽  
Adam Drewnowski ◽  
Eric Ravussin ◽  
...  

2009 ◽  
Vol 30 (4) ◽  
pp. 293-342 ◽  
Author(s):  
Evanthia Diamanti-Kandarakis ◽  
Jean-Pierre Bourguignon ◽  
Linda C. Giudice ◽  
Russ Hauser ◽  
Gail S. Prins ◽  
...  

Abstract There is growing interest in the possible health threat posed by endocrine-disrupting chemicals (EDCs), which are substances in our environment, food, and consumer products that interfere with hormone biosynthesis, metabolism, or action resulting in a deviation from normal homeostatic control or reproduction. In this first Scientific Statement of The Endocrine Society, we present the evidence that endocrine disruptors have effects on male and female reproduction, breast development and cancer, prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and cardiovascular endocrinology. Results from animal models, human clinical observations, and epidemiological studies converge to implicate EDCs as a significant concern to public health. The mechanisms of EDCs involve divergent pathways including (but not limited to) estrogenic, antiandrogenic, thyroid, peroxisome proliferator-activated receptor γ, retinoid, and actions through other nuclear receptors; steroidogenic enzymes; neurotransmitter receptors and systems; and many other pathways that are highly conserved in wildlife and humans, and which can be modeled in laboratory in vitro and in vivo models. Furthermore, EDCs represent a broad class of molecules such as organochlorinated pesticides and industrial chemicals, plastics and plasticizers, fuels, and many other chemicals that are present in the environment or are in widespread use. We make a number of recommendations to increase understanding of effects of EDCs, including enhancing increased basic and clinical research, invoking the precautionary principle, and advocating involvement of individual and scientific society stakeholders in communicating and implementing changes in public policy and awareness.


2016 ◽  
Vol 101 (4) ◽  
pp. 1318-1343 ◽  
Author(s):  
Nanette Santoro ◽  
Glenn D. Braunstein ◽  
Cherie L. Butts ◽  
Kathryn A. Martin ◽  
Michael McDermott ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document